The gene variant APOE4 is the most common genetic risk factor associated with late-onset Alzheimer's disease. A comprehensive, multilayer study reveals the molecular and cellular signatures of APOE4 in humans. See Article p.45
Notes
*This article and the paper under discussion1 were published online on 24 July 2013.
References
Rhinn, H. et al. Nature 500, 45–50 (2013).
Bettens, K., Sleegers, K. & Van Broeckhoven, C. Lancet Neurol. 12, 92–104 (2013).
Zhang, B. et al. Cell 153, 707–720 (2013).
Wijsman, E. M. et al. PLoS Genet. 7, e1001308 (2011).
Voineagu, I. et al. Nature 474, 380–384 (2011).
Geschwind, D. H. & Konopka, G. Nature 461, 908–915 (2009).
Miller, J. A., Oldham, M. C. & Geschwind, D. H. J. Neurosci. 28, 1410–1420 (2008).
Minami, S. S., Clifford, T. G., Hoe, H. S., Matsuoka, Y. & Rebeck, G. W. Neurobiol. Aging 33, 825.e15–825.e24 (2012).
Ihara, Y., Morishima-Kawashima, M. & Nixon, R. Cold Spring Harb. Persp. Med. 2, a006361 (2012).
Small, S. A. & Gandy, S. Neuron 52, 15–31 (2006).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Swarup, V., Geschwind, D. From big data to mechanism. Nature 500, 34–35 (2013). https://doi.org/10.1038/nature12457
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature12457
- Springer Nature Limited
This article is cited by
-
Addendum
Nature (2015)
-
Addendum
Nature (2015)
-
Analytical tools and current challenges in the modern era of neuroepigenomics
Nature Neuroscience (2014)